Elacytarabine has single-agent activity in patients  with advanced acute myeloid leukaemia.

O'Brien, Susan; Rizzieri, David A; Vey, Norbert; Ravandi, Farhad; Krug, Utz O; Sekeres, Mikkael A; Dennis, Mike; Venditti, Adriano; Berry, Donald A; Jacobsen, Tove Flem; Staudacher, Karin; Bergeland, Trygve; Giles, Francis J

Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia.

O'Brien, Susan; Rizzieri, David A; Vey, Norbert; Ravandi, Farhad; Krug, Utz O; Sekeres, Mikkael A; Dennis, Mike; Venditti, Adriano; Berry, Donald A; Jacobsen, Tove Flem; Staudacher, Karin; Bergeland, Trygve; Giles, Francis J.

Affiliation

O'Brien S; Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX 77230, USA. sobrien@mdanderson.org

Br J Haematol ; 158(5): 581-8, 2012 Sep.

Article in En | MEDLINE | ID: mdl-22702906

Subject(s)

Antimetabolites, Antineoplastic/administration & dosage; Cytarabine/analogs & derivatives; Leukemia, Myeloid, Acute/drug therapy; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic/adverse effects; Cytarabine/administration & dosage; Cytarabine/adverse effects; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute/mortality; Male; Middle Aged; Referral and Consultation; Remission Induction; Risk Factors; Stem Cell Transplantation; Survival Rate; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Cytarabine / Antimetabolites, Antineoplastic Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2012 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google